30 Nov 2021 - Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow talks about the recent presentation of data from the CHM 1101 (Chlorotoxin CAR T) Phase 1 clinical trial in glioblastoma patients.
23 Nov 2021 - WT Financial Group Limited (ASX:WTL) Founder and Managing Director Keith Cullen provides an introduction to the company's range of services to wholesale and retail clients.
22 Nov 2021 - Arovella Therapeutics Limited (ASX:ALA) CEO & Managing Director Dr Michael Baker provides an update on the company's invariant Natural Killer T (iNKT) cell platform and its oral spray delivery technology to treat cancer and conditions that affect the central nervous system.
16 Nov 2021 - Shaw and Partners Chief Investment Officer Martin Crabb discusses excess cash in the global economy, inflation, growth and promising investment sectors.
18 Nov 2021 - Etherstack Limited (ASX:ESK) CEO and Executive Director David Deacon introduces the company's push-to-talk communications technology for essential services.
12 Nov 2021 - Novatti Group Limited (ASX:NOV) CEO Peter Cook talks about the company's acquiring business and recent licences with Visa and Mastercard.
05 Nov 2021 - BrainChip Holdings Limited (ASX:BRN) Vice President of Worldwide Sales and Marketing Rob Telson talks about the company and the future of artificial intelligence.
27 Sep 2021 - LBT Innovations Limited (ASX:LBT) CEO and Managing Director Brent Barnes discusses the appointment of a US distributor for the company's APAS Independence instrument.
27 Sep 2021 - PropTech Group Limited (ASX:PTG) CEO and Managing Director Joe Hanna introduces the company's suite of market-leading real estate software solutions, discussing FY21 results and outlook.
23 Sep 2021 - AD1 Holdings Limited (ASX:AD1) CEO and Managing Director Brendan Kavenagh provides an update on the company's suite of software as a service businesses, FY21 results and outlook.
